Jazz Pharmaceuticals presents Xywav sleep disorder data at SLEEP 2026 conference
Go back to Jazz Pharmaceuticals presents Xywav sleep disorder data at SLEEP 2026 conference| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 250.41 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $250.41 | 52 Week High | $160.00 | |||
| Open | $250.41 | 52 Week Low | $95.80 | |||
| Day High | $250.41 | P/E | 46.54 | |||
| Day Low | $250.41 | EPS | $5.38 | |||
| Volume | 119 | |||||
